The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The departure comes as Sanofi ...
Sanofi is tight-lipped about the future of its underwhelming pact with Denali Therapeutics after the French pharma scrapped what appeared to be the final RIPK1 inhibitor from the deal. The Paris-based ...
Sanofi SAN0.98%increase; green up pointing triangle said its amlitelimab drug confirmed its potential to treat eczema in two late-phase studies. The French drugmaker said Friday that amlitelimab ...
Deal follows acquisitions of Vicebio and BluePrint Medicines Sanofi keen to diversify growth beyond asthma drug Dupixent Expects to finalise Dynavax deal in Q1 2026 Dynavax shares soar 39% The ...
Sanofi said on Wednesday it will buy U.S. biotech Dynavax Technologies for around $2.2 billion (1.9 billion euros) in an agreed deal that will add an adult hepatitis B vaccine and a promising ...
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. Sanofi shares slid Thursday after ...
Sanofi tightens grip on RSV, paying $1.15B upfront for Vicebio and boosting its pipeline beyond mRNA
Sanofi has struck a deal to buy Vicebio for $1.15 billion upfront, securing preclinical and phase 1 vaccine candidates to expand its respiratory syncytial virus (RSV) pipeline beyond mRNA. The French ...
Aerials of modern-day Sanofi Swiftwater campus in Monroe County Global healthcare company Sanofi, headquartered in Paris, France, is announcing another pricey purchase in the U.S. Sanofi will buy ...
JERUSALEM, Dec 17 (Reuters) - (This Dec.17 story has been corrected to say the results were for ulcerative colitis, not for both the diseases, in paragraph 5) Sign up here. Teva and Sanofi said last ...
Sanofi is joining its fellow drugmakers in trying to put new restrictions on savings sent to hospitals in a federal drug discount program. A spokesperson for Sanofi confirmed plans to implement a ...
Thursday’s agreement with Orano Med is the second in as many months. Sanofi in September made its first foray into the radioligand space with a $110 million licensing deal with Orano Med and Texas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results